Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size
Year: 2025
Type: article
Study design: Observational Study
Abstract: The dynamics of the HIV reservoir during antiretroviral therapy (ART) exhibit variability, with a pronounced decline during the initial years of treatment. However, the identification of biomarkers and host factors associated with the decay of the different forms of HIV proviruses remains to be fully elucidated. We conducted a longitudinal study on people with HIV provided by the Spanish National HIV cohort. We assessed the HIV-DNA levels by Intact Proviral DNA Assay, and inflammatory markers using the Proximity Extension Assay, before and after ART initiation. A multivariate linear regression model was employed to identify potential predictive markers. Our results highlight the identification of novel inflammatory markers, such as ADA, DNER, CDCP1, SCF, among others, that varied significantly over ART initiation. In addition, we observed several markers associated with intact HIV-DNA before ART initiation (CD8A, CX3CL1, and ST1A1) or during undetectable viral load post-ART (IL-10). Moreover, up to five markers were able to predict the intact HIV reservoir decay over ART. The strongest predictor was Stem Cell Factor (SCF), where higher baseline levels of this marker were associated with a greater decline in the intact HIV reservoir. In conclusion, we have identified inflammatory markers associated with the size and dynamics of the HIV-DNA reservoir. These findings provide new insights that could contribute to the development of multi-targeted intervention strategies aimed at modulating or monitoring the HIV reservoir size.
DOI: 10.3390/ijms26178430
Authors: Erick De La Torre Tarazona, Elisa Moraga, María Fons-Contreras, Raúl Vaquer, Sonsoles Sánchez-Palomino, Germán Vallejo-Palma, Sergio Calderón-Vicente, Sònia Vicens-Artés, Teresa Aldamiz-Echevarria, Marianela Ciudad Sañudo, Cristina Moreno, Inés Armenteros-Yeguas, Juan Tiraboschi, Sergio Reus Bañuls, José Alcamí, Sergio Serrano-Villar, Santiago Moreno, on behalf of the CoRIS cohort
Institutions: Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Hospital Universitario La Paz, Universidad Complutense de Madrid, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital Universitario de La Princesa, Centro Nacional de Epidemiología, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Bellvitge University Hospital, Hospital General Universitario de Alicante Doctor Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Universidad de Alcalá
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
Awards: G2569358847, Administración de altas dosis de fármacos antirretrovirales para la eliminar el reservorio latente del VIH-1 (Estudio DOSAGE), G5677652633, Momento de la Admistración de los Agentes Reactivadores de la Latencia para Eliminar los Reservorios Latentes del VIH-1: Impacto de la Administración en el Inicio del Tratamiento Antirretroviral
OpenAlex ID: W4413824827
